|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: KCNQ1OT1 |
Gene summary for KCNQ1OT1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | KCNQ1OT1 | Gene ID | 10984 |
| Gene name | KCNQ1 opposite strand/antisense transcript 1 | |
| Gene Alias | KCNQ1-AS2 | |
| Cytomap | 11p15.5 | |
| Gene Type | ncRNA | GO ID | GO:0006139 | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 10984 | KCNQ1OT1 | GSM4909285 | Human | Breast | IDC | 4.77e-24 | 5.63e-01 | 0.21 |
| 10984 | KCNQ1OT1 | GSM4909286 | Human | Breast | IDC | 3.52e-11 | -3.27e-01 | 0.1081 |
| 10984 | KCNQ1OT1 | GSM4909293 | Human | Breast | IDC | 6.97e-17 | 4.00e-01 | 0.1581 |
| 10984 | KCNQ1OT1 | GSM4909295 | Human | Breast | IDC | 2.28e-04 | 4.62e-01 | 0.0898 |
| 10984 | KCNQ1OT1 | GSM4909298 | Human | Breast | IDC | 1.55e-31 | 7.12e-01 | 0.1551 |
| 10984 | KCNQ1OT1 | GSM4909311 | Human | Breast | IDC | 7.71e-11 | -3.29e-01 | 0.1534 |
| 10984 | KCNQ1OT1 | GSM4909312 | Human | Breast | IDC | 2.23e-08 | -3.25e-01 | 0.1552 |
| 10984 | KCNQ1OT1 | GSM4909315 | Human | Breast | IDC | 1.03e-07 | -3.14e-01 | 0.21 |
| 10984 | KCNQ1OT1 | GSM4909317 | Human | Breast | IDC | 6.46e-15 | 5.37e-01 | 0.1355 |
| 10984 | KCNQ1OT1 | GSM4909319 | Human | Breast | IDC | 7.71e-11 | -2.98e-01 | 0.1563 |
| 10984 | KCNQ1OT1 | brca10 | Human | Breast | Precancer | 5.71e-03 | -2.77e-01 | -0.0029 |
| 10984 | KCNQ1OT1 | NCCBC14 | Human | Breast | DCIS | 1.73e-08 | -1.28e-01 | 0.2021 |
| 10984 | KCNQ1OT1 | NCCBC5 | Human | Breast | DCIS | 1.30e-07 | -3.08e-01 | 0.2046 |
| 10984 | KCNQ1OT1 | DCIS2 | Human | Breast | DCIS | 3.27e-38 | 6.14e-01 | 0.0085 |
| 10984 | KCNQ1OT1 | CCI_1 | Human | Cervix | CC | 3.77e-04 | 2.97e-01 | 0.528 |
| 10984 | KCNQ1OT1 | CCI_2 | Human | Cervix | CC | 2.86e-05 | 4.37e-01 | 0.5249 |
| 10984 | KCNQ1OT1 | CCI_3 | Human | Cervix | CC | 1.65e-18 | 6.72e-01 | 0.516 |
| 10984 | KCNQ1OT1 | Tumor | Human | Cervix | CC | 8.77e-10 | 1.96e-01 | 0.1241 |
| 10984 | KCNQ1OT1 | sample1 | Human | Cervix | CC | 2.17e-17 | 6.08e-01 | 0.0959 |
| 10984 | KCNQ1OT1 | sample3 | Human | Cervix | CC | 5.84e-20 | 3.89e-01 | 0.1387 |
| Page: 1 2 3 4 5 6 7 8 9 10 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Breast |  | IDC: Invasive ductal carcinoma |
| DCIS: Ductal carcinoma in situ | ||
| Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers | ||
| Cervix |  | CC: Cervix cancer |
| HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions | ||
| N_HPV: HPV-infected normal cervix | ||
| Endometrium |  | AEH: Atypical endometrial hyperplasia |
| EEC: Endometrioid Cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Lung |  | AAH: Atypical adenomatous hyperplasia |
| AIS: Adenocarcinoma in situ | ||
| IAC: Invasive lung adenocarcinoma | ||
| MIA: Minimally invasive adenocarcinoma | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00313318 | Lung | IAC | positive regulation of cellular catabolic process | 98/2061 | 427/18723 | 7.79e-13 | 9.25e-10 | 98 |
| GO:00609646 | Lung | IAC | regulation of gene silencing by miRNA | 18/2061 | 49/18723 | 2.10e-06 | 9.45e-05 | 18 |
| GO:00601475 | Lung | IAC | regulation of posttranscriptional gene silencing | 18/2061 | 52/18723 | 5.60e-06 | 2.13e-04 | 18 |
| GO:00609664 | Lung | IAC | regulation of gene silencing by RNA | 18/2061 | 53/18723 | 7.61e-06 | 2.64e-04 | 18 |
| GO:00105864 | Lung | IAC | miRNA metabolic process | 12/2061 | 27/18723 | 1.09e-05 | 3.39e-04 | 12 |
| GO:00064017 | Lung | IAC | RNA catabolic process | 54/2061 | 278/18723 | 2.27e-05 | 6.28e-04 | 54 |
| GO:00609683 | Lung | IAC | regulation of gene silencing | 22/2061 | 81/18723 | 4.37e-05 | 1.04e-03 | 22 |
| GO:00609652 | Lung | IAC | negative regulation of gene silencing by miRNA | 10/2061 | 22/18723 | 4.73e-05 | 1.09e-03 | 10 |
| GO:00601492 | Lung | IAC | negative regulation of posttranscriptional gene silencing | 10/2061 | 24/18723 | 1.17e-04 | 2.22e-03 | 10 |
| GO:00609672 | Lung | IAC | negative regulation of gene silencing by RNA | 10/2061 | 24/18723 | 1.17e-04 | 2.22e-03 | 10 |
| GO:0060969 | Lung | IAC | negative regulation of gene silencing | 10/2061 | 29/18723 | 7.11e-04 | 9.50e-03 | 10 |
| GO:00105872 | Lung | IAC | miRNA catabolic process | 6/2061 | 12/18723 | 9.06e-04 | 1.11e-02 | 6 |
| GO:00346557 | Lung | IAC | nucleobase-containing compound catabolic process | 63/2061 | 407/18723 | 3.31e-03 | 2.84e-02 | 63 |
| GO:20006281 | Lung | IAC | regulation of miRNA metabolic process | 5/2061 | 12/18723 | 6.55e-03 | 4.60e-02 | 5 |
| GO:000989613 | Lung | AIS | positive regulation of catabolic process | 103/1849 | 492/18723 | 9.59e-14 | 1.86e-10 | 103 |
| GO:003133113 | Lung | AIS | positive regulation of cellular catabolic process | 89/1849 | 427/18723 | 6.12e-12 | 4.46e-09 | 89 |
| GO:006096412 | Lung | AIS | regulation of gene silencing by miRNA | 16/1849 | 49/18723 | 1.08e-05 | 4.40e-04 | 16 |
| GO:006014712 | Lung | AIS | regulation of posttranscriptional gene silencing | 16/1849 | 52/18723 | 2.51e-05 | 8.13e-04 | 16 |
| GO:006096612 | Lung | AIS | regulation of gene silencing by RNA | 16/1849 | 53/18723 | 3.27e-05 | 1.01e-03 | 16 |
| GO:006096811 | Lung | AIS | regulation of gene silencing | 19/1849 | 81/18723 | 2.73e-04 | 5.19e-03 | 19 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |